AFRMF.US Alphaform AG
- Market cap
- USD 748.00
- P/E
- -
- P/B
- -
- ROE
- -48.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2015.
Is AFRMF.US undervalued?
Graham numberThe Graham number of Alphaform AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Alphaform AG fundamental analysis
No fundamental analysis for Alphaform AG yet.
Alphaform AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Alphaform AG
Alphaform AG, together with its subsidiaries, engages in the provision of generative 3D layering technologies, and manufacture of medical products in Germany, rest of Europe, Turkey, and the United States. It operates through AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting segments. The company's services comprise consulting on the content and planning of the product development process; and manufacturing virtual or real prototypes, and small series of p…
Full company profileAlphaform AG financial statements
2015 annualized: Fiscal year 2015 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2015, the balance sheet is the latest quarter. Figures change when the annual report is published.
Alphaform AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 17.9M | 20.8M | 22.1M | 21.4M | 19.4M | 22.6M | 26.3M | 27.4M | 26.4M | 30.3M | 32.9M |
| Gross Profit | 12.3M | 14.4M | 14.1M | 13.4M | 12.5M | 15.2M | 17.1M | 18.9M | 14.1M | 19.6M | 21.5M |
| Operating Income | -4.31M | 1.67M | 1.50M | -503K | -3.77M | -1.32M | -1.29M | 766K | -5.79M | -2.61M | -4.07M |
| EBITDA | 1.62M | 7.90M | 3.46M | 1.77M | -1.36M | 595K | 952K | 2.06M | -3.51M | -1.32M | -2.39M |
| Net Income | -6.38M | 2.18M | 2.22M | -661K | -3.80M | -1.39M | -1.59M | 537K | -6.17M | -3.11M | -4.56M |
| EPS | -1.18 | 0.40 | 0.41 | -0.12 | -0.70 | -0.26 | -0.29 | 0.10 | -1.14 | -0.41 | -0.58 |
| Balance Sheet | |||||||||||
| Total Assets | 19.7M | 22.1M | 24.3M | 27.5M | 26.6M | 24.7M | 20.5M | 21.4M | 15.8M | 20.0M | 19.6M |
| Total Liabilities | 3.46M | 2.01M | 2.12M | 8.30M | 11.2M | 10.7M | 8.24M | 8.60M | 9.14M | 10.4M | 10.1M |
| Shareholders' Equity | 16.2M | 18.4M | 20.7M | 19.2M | 15.4M | 14.0M | 12.3M | 12.8M | 6.63M | 9.54M | 9.41M |
| Cash & Short-term Investments | 4.36M | 10.6M | 11.9M | 5.22M | 3.73M | 2.21M | 2.07M | 1.63M | 1.15M | 2.32M | 785K |
| Total Debt | 625K | - | - | 2.69M | 972K | 5.54M | 2.87M | 2.39M | 3.16M | 2.05M | 2.24M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 2.12M | 4.27M | 2.66M | 1.86M | -825K | -183K | 1.73M | 241K | -336K | -2.03M | -12.3M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 2.25M | 812K | 1.82M | 603K | 652K | 995K | 2.59M | 3.64M |
| Free Cash Flow | 2.12M | 4.27M | 2.66M | -383K | -1.64M | -2.00M | 1.13M | -411K | -1.33M | -4.62M | -15.9M |
| Ratios | |||||||||||
| ROE | -39.3% | 11.8% | 10.7% | -3.4% | -24.6% | -9.9% | -12.9% | 4.2% | -93.1% | -32.6% | -48.5% |
| ROA | -32.4% | 9.8% | 9.1% | -2.4% | -14.2% | -5.6% | -7.7% | 2.5% | -39.1% | -15.5% | -23.2% |
| Net Profit Margin | -35.7% | 10.5% | 10.0% | -3.1% | -19.5% | -6.1% | -6.0% | 2.0% | -23.4% | -10.3% | -13.8% |
| Debt to Equity | 0.04x | - | - | 0.14x | 0.06x | 0.40x | 0.23x | 0.19x | 0.48x | 0.21x | 0.24x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Alphaform AG dividends
Alphaform AG has not paid dividends in the last 9 fiscal years.
Last stock split: 1019:1000 on Sep 18, 2014.
Who owns Alphaform AG
Ownership data of Alphaform AG is not available yet.
Alphaform AG company profile
- Company name
- Alphaform AG
- Ticker
- AFRMF.US
- ISIN
- DE0005487953
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 258
- Fiscal year end
- December
- Address
- Kapellenstrasse 10, Feldkirchen, Germany, 85622
- Phone
- 49 89 9050 020
- Website
- protolabs.com
About Alphaform AG
Alphaform AG, together with its subsidiaries, engages in the provision of generative 3D layering technologies, and manufacture of medical products in Germany, rest of Europe, Turkey, and the United States. It operates through AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting segments. The company's services comprise consulting on the content and planning of the product development process; and manufacturing virtual or real prototypes, and small series of products. It manufactures prototype parts and models from rein and plastic powder; and plastic and metal parts for the automotive industry. The company also provides medical implants, such as hip joint implants or cranial trauma plates; and knee implants and clips to fix ligaments for use in tendon operations. It serves automotive, machinery, plant and commercial vehicle construction, aerospace and aviation, tool making, medical technology, household appliances, and telecommunications sectors, as well as electro-technical companies, universities, and research institutions. The company was founded in 1995 and is headquartered in Feldkirchen, Germany.
Alphaform AG management
2- Dr. Hanns-Dieter AberleChief Executive Officer
- Mr. Thomas KresserMember of Management Board · born 1964